Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
Robert Königsberg(Kaiser-Franz-Josef-Spital), Christian Dittrich(Leibniz Institute for Agricultural Engineering and Bioeconomy), Eva Obermayr(Comprehensive Cancer Center Vienna), Giovanna Bises(Medical University of Vienna), Marcus Hudec(University of Vienna), Robert Zeillinger(Comprehensive Cancer Center Vienna), Maria De Santis(Medical University of Vienna), Georg Pfeiler(Medical University of Vienna), Fritz Wrba(University of Vienna), Margit Gneist(Kaiser-Franz-Josef-Spital)
Cited by 239
Related Papers
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
|European Urology|2008|617